Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › Washington › Spokane
Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Spokane, WA keessatti
Qorannoo 12 Kansara Qara'a Non-Small Cell f Spokane fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 2
- Medical Oncology Associates - Spokane /ID# 277172, Spokane
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Namoota walitti qabaa jiraSadarkaa 3
- Local Institution - 0384, Spokane
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 2
- Summit Cancer Centers, Spokane
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Spokane
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Summit Cancer Treatment Center, Spokane
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Namoota walitti qabaa jiraSadarkaa 1/2
- Providence Sacred Heart Medical Center, Spokane
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- Summit Cancer Center, Spokane
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
Namoota walitti qabaa jiraSadarkaa 3
- Medical Oncology Associates - Summit Cancer Centers, Spokane
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Namoota walitti qabaa jiraSadarkaa 3
- MultiCare Deaconess Cancer and Blood Specialty Center - Downtown, Spokane
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Namoota walitti qabaa jiraSadarkaa 1
- Medical Oncology Associates, Spokane
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 2
- USA07-0, Spokane
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Research Site 105, Spokane
Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti
- Houston, TXQorannoo 145
- New York City, NYQorannoo 121
- Arlington, VAQorannoo 104
- Nashville, TNQorannoo 97
- Boston, MAQorannoo 90
- Los Angeles, CAQorannoo 87
- St. Louis, MOQorannoo 73
- Chicago, ILQorannoo 61
- Baltimore, MDQorannoo 60
- San Antonio, TXQorannoo 59
- Columbus, OHQorannoo 57
- Washington, DCQorannoo 55
Qorannoo biroo Spokane keessatti
- Saree OljooQorannoo 8
- Kansarii OvariiQorannoo 8
- Kansarii ColorectalQorannoo 8
- Dhibee ParkinsonQorannoo 7
- Saree (Gosoota Hunda)Qorannoo 6
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 6
- Kansarii ProstateQorannoo 6
- Luukemiya Limfoositiikii KeessummaaQorannoo 6
- Degenereshinii MakulaariiQorannoo 5
- MelanomaQorannoo 5
- Kansaar Onnee Triple-NegativeQorannoo 5
- Atrophy GeographicaQorannoo 5
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.